Search Results 211-220 of 16720 for CLL

1. B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

   B-Cell Lymphoproliferative Disorders: Susan L. Slager · Family Study of CLL and Other Lymphoproliferative Disorders · Epidemiology of Chronic Lymphocytic Leukemia ...

2. Hematology - Clinical trials

   Anticipated time on study is up to 5 years. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL) ...

3. Bendamustine (intravenous route) - Mayo Clinic

   Bendamustine injection is used to treat chronic lymphocytic leukemia (CLL, cancer of white blood cells) and indolent B-cell non-Hodgkin's lymphoma (NHL) in ...

4. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

   ... CLL defined by 2008 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria; Must have received one prior therapy for CLL; Must meet one or ...

5. Mazie Tsang, M.D. - Doctors and Medical Staff - Mayo Clinic

   ... Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL). 2023. Selected for ParticipationAcademy of Next Wave Investigators in Chronic Lymphocytic ...

6. Clinical trials - Oncology (Medical)

   A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

7. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

   This study evaluates CLR 131 in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small ...

8. Talal Hilal, M.D. - Doctors and Medical Staff - Mayo Clinic

   Talal Hilal, M.D., is a hematologist/oncologist and bone marrow transplant physician with a clinical focus on chronic lymphocytic leukemia, lymphoid ...

9. Clinical trials - Oncology (Medical)

   A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

10. A Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...